Dr Boreham's Crucible: Orthocell
Micro-cap biotech Orthocell is aiming to emulate the successful growth story of Polynovo, nowadays capitalised at $1.1bn
Source: fnarena.com
Stay updated with breaking news from Prof Lars Lidgren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Micro-cap biotech Orthocell is aiming to emulate the successful growth story of Polynovo, nowadays capitalised at $1.1bn